Biomarker test is based on technology developed at WashU Medicine.
FDA clears blood test to aid evaluation for Alzheimer’s disease (Links to an external site)
Biomarker test is based on technology developed at WashU Medicine.
Findings may offer a new way to fight brain cancer, neurodegenerative disease.
Large analysis of patient outcomes shows that extent of tumor ablation, treatment timing extends survival.
Finding from mouse study could lead to targeted treatments for chronic nerve pain.
Study identifies brain differences tied to sensory distress, often linked to anxiety and autism.
Mouse study finds changes to DNA packaging form molecular memory of trauma, make brain vulnerable to future stress.
New technique wrangles evasive proteins to dissect the cause of diseases and design potential new therapeutics.
Family-based treatment helped nearly half of kids in clinical trial reach healthier weight.
Multiyear program will provide hands-on training at the pharmaceutical company, fund translational neuroscience research at WashU.
First device to identify dangerous stroke complication developed at WashU Medicine.